Skip to search formSkip to main contentSkip to account menu

deglycobleomycin

Known as: deglycosylated-bleomycin, Bleomycinamide, N1-(4-((aminoiminomethyl)amino)butyl)-41-O-de(2-O-(3-O-(aminocarbonyl)-alpha-D-mannopyranosyl)-alpha-L-gulopyranosyl)-, deglyco-bleomycin 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
The disaccharide moiety is responsible for the tumor cell targeting properties of bleomycin (BLM). While the aglycon… 
Highly Cited
2013
Highly Cited
2013
Background: Little is known about the enzymes involved in O-glycosylation of arabinogalactan proteins (AGPs) in plants. Results… 
Highly Cited
2013
Highly Cited
2013
In a recent study, the well-documented tumor targeting properties of the antitumor agent bleomycin (BLM) were studied in cell… 
2008
2008
Saffron (Crocus sativus L.) shows different biological properties, some of which relate to its special components including… 
2003
2003
The bleomycins (BLMs) are structurally related glycopeptide antibiotics isolated from Streptomyces verticillus that mediate the… 
Highly Cited
1995
Highly Cited
1995
CHIP28 occurs naturally in glycosylated and nonglycosylated forms. The purpose of this study was to determine the role of… 
1992
1992
Female rabbits (n = 36, 6 per group) were immunized with: (i) solubilized isolated porcine zona pellucida (SIZP), which contains… 
1987
1987
Zonae pellucidae (ZP) were isolated from 1,500 porcine ovaries and heat solubilized to generate approximately 15 mg ZP…